Hitomi Umeguchi and his teamwork [31] showed that HGF in plasma was significantly higher in the advanced stage of cancer and predicted poor survival as determined using 315 plasma samples from 225 lung cancer patients. The gene discussed is HGF; the disease is lung carcinoma.